Results 241 to 250 of about 362,523 (334)

Cross-Modality Masked Learning for Survival Prediction in ICI Treated NSCLC Patients [PDF]

Qilong Xing, Zikai Song, Bingxin Gong, Lian Yang, Junqing Yu, Wei Yang   +5 more
openalex   +1 more source

Recent Progress in the Development of Metal‐Based Radiosensitizations for Cancer Therapy: A Review

Rare Metals, EarlyView.
ABSTRACT Radiotherapy (RT) remains an indispensable means in cancer treatment; however, its therapeutic efficacy is often limited by tumor radioresistance and side effect of damage to healthy tissue. The advances in nanotechnology have propelled metal radiosensitizers to forefront of precision medicine.
Xiao‐Xia Wu, Ding‐Hu Zhang, Chuan Hu, Yi‐Nan Ding, Kun Chen, Yi Jiang, Jun Luo, Fei Cao, Wei‐Yuan Hao, Bin‐Yan Zhong, Jie Lin, Dong Xu, Jia‐Ping Zheng   +12 more
wiley   +1 more source

Targeting MET in advanced and metastatic non-small cell lung cancer: a literature review of the current landscape. [PDF]

Transl Cancer Res
Herrmann A, Grant C, Bazhenova L.
europepmc   +1 more source

Advances in Elemene Nanodelivery Systems: From Material Design to Disease Treatment

Rare Metals, EarlyView.
ABSTRACT Elemene (ELE) is a bioactive sesquiterpenoid extracted from traditional Chinese herbs, demonstrating broad‐spectrum antitumor, anti‐inflammatory, and analgesic properties with significant therapeutic potential. However, its clinical utility is constrained by inherent physicochemical limitations, including volatility and hydrophobicity, which ...
Xiao Wang, Jiatong Lin, Yi Peng, Zehua Wu, Yingying Liu, Wei Duan, Qiaolin Wei, Jia‐Wei Shen, Jiang‐Xing Chen, Yong Guo   +9 more
wiley   +1 more source

Advances on drug therapy for KRAS^G12C-mutant non-small-cell lung cancer. [PDF]

Transl Oncol
Tian T, Li W.
europepmc   +1 more source

Oligometastatic NSCLC

Oncology Times, 2019
openaire   +2 more sources

Engineering a Tumor‐Targeted MgH2@Lip/PD‐L1 Nanoplatform for Synergistic Hydrogen Therapy and Immune Activation

Rare Metals, EarlyView.
ABSTRACT Lung cancer remains the leading cause of cancer‐related deaths worldwide, yet immune checkpoint blockade (ICB) is often compromised by an immunosuppressive tumor microenvironment (TME) with acidosis, hypoxia, and poor T cell infiltration. Here, we develop a TME‐responsive nanoplatform (MgH2@Lip/PD‐L1) that couples hydrogen gas therapy with PD ...
Xuyu Gu, Ming Deng, Tao Ge, Li Xu, Xinnan Xu, Kaiqi Jin   +5 more
wiley   +1 more source

<i>Herba Patriniae</i> Component Linarin Induces Cell Cycle Arrest and Senescence in Non-Small-Cell Lung Cancer Associated with Cyclin A2 Downregulation. [PDF]

Pharmaceuticals (Basel)
Xie W, Li X, Huang D, Xu J, Yu M, Li Y, Wang QK.   +6 more
europepmc   +1 more source

Expression of High Mobility Group Box - B1 (HMGB-1) and Matrix Metalloproteinase-9 (MMP-9) in Non-small Cell Lung Cancer (NSCLC)

, 2014
Jingluan Wang, Dawei Wu, Zhaozhong Cheng, Weizhong Han, XU Sheng-wei, Nina Sun   +5 more
openalex   +2 more sources

Optimizing radiation dose and fractionation for the definitive treatment of locally advanced non-small cell lung cancer [PDF]

, 2018
Bradley, Jeffrey D, Roach, Michael C, Robinson, Cliff G   +2 more
core   +1 more source